Iancu S C, Batelaan N M, Zweekhorst M B M, Bunders J F G, Veltman D J, Penninx B W J H, van Balkom A J L M
Athena Institute, Department of Innovation in Health and Life Sciences, VU University Amsterdam, The Netherlands.
Department of Psychiatry and EMGO+ Institute for Health and Care Research, VU University Medical Centre and GGZ InGeest, Amsterdam, The Netherlands.
Psychol Med. 2014 Feb;44(3):593-605. doi: 10.1017/S0033291713001050. Epub 2013 May 10.
Anxiety disorders are associated with substantial functional limitations but the course of functioning following symptom remission remains largely unknown.
Using data from the Netherlands Study of Depression and Anxiety (NESDA), we examined the 2-year trajectories of functioning in participants with chronic (n = 586) or remitting anxiety disorders (n = 385) and in healthy controls (n = 585). In participants with remitting anxiety disorders, we identified predictors of functioning from among sociodemographic, clinical and vulnerability variables. Data were analysed using linear mixed models (LMMs). Functioning was assessed with the World Health Organization Disability Assessment Schedule II (WHO DAS II).
At baseline, participants with remitting anxiety disorders functioned significantly better than those with chronic anxiety disorders, but significantly worse than controls. In both anxiety disorder groups, most impairment was reported in social functioning, occupational functioning and cognition. During the follow-up, functioning improved in both groups, probably due to treatments received. Participants who achieved symptom remission experienced moderate improvements in social functioning and cognition but not in occupational functioning. Of those who remitted, 45.8% reported functioning scores similar to healthy controls whereas 28.5% still functioned at the level of those with chronic anxiety disorders. Worse functioning was predicted by severe anxiety disorders, use of psychological treatment, co-morbid depressive disorders and maladaptive personality traits.
In anxiety disorders, symptom remission is accompanied by improvements in functioning but significant functional impairments may persist because of co-morbid disorders, lower functioning prior to the onset of the anxiety disorder or residual subthreshold anxiety symptoms.
焦虑症与严重的功能受限相关,但症状缓解后的功能变化过程在很大程度上仍不清楚。
利用荷兰抑郁与焦虑研究(NESDA)的数据,我们研究了慢性焦虑症患者(n = 586)、缓解期焦虑症患者(n = 385)和健康对照者(n = 585)的2年功能轨迹。在缓解期焦虑症患者中,我们从社会人口学、临床和易感性变量中确定了功能的预测因素。使用线性混合模型(LMMs)对数据进行分析。功能通过世界卫生组织残疾评估量表第二版(WHO DAS II)进行评估。
在基线时,缓解期焦虑症患者的功能明显优于慢性焦虑症患者,但明显差于对照组。在两个焦虑症组中,社会功能、职业功能和认知方面的损害最为严重。在随访期间,两组的功能都有所改善,可能是由于接受了治疗。症状缓解的参与者在社会功能和认知方面有中度改善,但职业功能没有改善。在缓解的参与者中,45.8%的人报告功能得分与健康对照者相似,而28.5%的人仍处于慢性焦虑症患者的功能水平。严重焦虑症、使用心理治疗、共病抑郁症和适应不良人格特质预示着功能较差。
在焦虑症中,症状缓解伴随着功能改善,但由于共病、焦虑症发作前功能较低或残留的阈下焦虑症状,严重的功能损害可能会持续存在。